PCR.WA(PCR.WA)
PCR.WA
No analyst ratings available
No analyst price targets available for PCR.WA
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.03B | $2.14B | $2.20B | $2.17B | $2.06B |
| Low | $1.95B | $2.10B | $2.20B | $2.13B | $2.03B |
| High | $2.11B | $2.18B | $2.21B | $2.21B | $2.10B |
| EBITDA Avg | $460M | $485M | $500M | $493M | $468M |
| Low | $443M | $476M | $499M | $484M | $459M |
| High | $477M | $494M | $500M | $502M | $476M |
| EBIT Avg | $303M | $320M | $329M | $325M | $308M |
| Low | $292M | $314M | $329M | $319M | $303M |
| High | $315M | $325M | $329M | $331M | $314M |
| Net Income Avg | $154M | $176M | $183M | $199M | — |
| Low | $151M | $172M | $165M | $194M | — |
| High | $158M | $180M | $202M | $203M | — |
| EPS Avg | $7.77 | $8.86 | $9.22 | $10.00 | — |
| Low | $7.59 | $8.65 | $8.29 | $9.76 | — |
| High | $7.95 | $9.07 | $10.16 | $10.24 | — |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 2 | 1 / 1 | 1 / — |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $489M | $481M |
| Low | $489M | $481M |
| High | $489M | $481M |
| EBITDA Avg | $111M | $109M |
| Low | $111M | $109M |
| High | $111M | $109M |
| EBIT Avg | $73M | $72M |
| Low | $73M | $72M |
| High | $73M | $72M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |